MUPIROCIN RESISTANCE AMONG CONSECUTIVE ISOLATES OF OXACILLIN-RESISTANT AND BORDERLINE OXACILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS AT A UNIVERSITY HOSPITAL

被引:37
作者
LAYTON, MC
PATTERSON, JE
机构
[1] YALE UNIV,SCH MED,DEPT MED,INFECT DIS SECT,NEW HAVEN,CT 06520
[2] YALE UNIV,SCH MED,DEPT LAB MED,NEW HAVEN,CT 06520
关键词
D O I
10.1128/AAC.38.7.1664
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Mupirocin resistance was determined in consecutive oxacillin-resistant and borderline oxacillin-resistant Staphylococcus aureus clinical isolates collected over 14 months at a university hospital during 1991 and 1992. Twenty of 86 (23%) oxacillin-resistant and borderline oxacillin-resistant S. aureus isolates were mupirocin resistant; 80% were high-level resistant. Prior mupirocin use was a significant risk factor (relative risk, 6.08; 95% confidence interval, 3.7 to 9.99). Seven of 20 resistant isolates were distinct strains, as determined by pulsed-field gel electrophoresis typing. Two instances of clonal dissemination of a single strain occurred, but several other distinct mupirocin-resistant strains were documented. Mupirocin resistance was unexpectedly common among these isolates.
引用
收藏
页码:1664 / 1667
页数:4
相关论文
共 38 条
[1]   DETECTION OF METHICILLIN RESISTANCE IN STAPHYLOCOCCI BY USING A DNA PROBE [J].
ARCHER, GL ;
PENNELL, E .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (09) :1720-1724
[2]  
BAIRD D, 1987, LANCET, V2, P387
[3]   THE VALUE OF NASAL MUPIROCIN IN CONTAINING AN OUTBREAK OF METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS IN AN ORTHOPEDIC UNIT [J].
BARRETT, SP .
JOURNAL OF HOSPITAL INFECTION, 1990, 15 (02) :137-142
[4]   THE USE OF NASAL MUPIROCIN OINTMENT TO PREVENT STAPHYLOCOCCUS-AUREUS BACTEREMIAS IN HEMODIALYSIS-PATIENTS - AN ANALYSIS OF COST-EFFECTIVENESS [J].
BOELAERT, JR ;
DEBAERE, YA ;
GEERNAERT, MA ;
GODARD, CA ;
VANLANDUYT, HW .
JOURNAL OF HOSPITAL INFECTION, 1991, 19 :41-46
[5]   USE OF MUPIROCIN OINTMENT IN THE TREATMENT OF SECONDARILY INFECTED DERMATOSES [J].
BRENEMAN, DL .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1990, 22 (05) :886-892
[6]   MECHANISM OF MUPIROCIN TRANSPORT INTO SENSITIVE AND RESISTANT-BACTERIA [J].
CAPOBIANCO, JO ;
DORAN, CC ;
GOLDMAN, RC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (02) :156-163
[7]   MUPIROCIN (PSEUDOMONIC ACID) - A PROMISING NEW TOPICAL ANTIMICROBIAL AGENT [J].
CASEWELL, MW ;
HILL, RLR .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1987, 19 (01) :1-5
[8]   ELIMINATION OF NASAL CARRIAGE OF STAPHYLOCOCCUS-AUREUS WITH MUPIROCIN (PSEUDOMONIC ACID) - A CONTROLLED TRIAL [J].
CASEWELL, MW ;
HILL, RLR .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 17 (03) :365-372
[9]   INVITRO ACTIVITY OF MUPIROCIN (PSEUDOMONIC ACID) AGAINST CLINICAL ISOLATES OF STAPHYLOCOCCUS-AUREUS [J].
CASEWELL, MW ;
HILL, RLR .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1985, 15 (05) :523-531
[10]   MUPIROCIN-RESISTANT STAPHYLOCOCCUS-AUREUS [J].
COOKSON, BD ;
LACEY, RW ;
NOBLE, WC ;
REEVES, DS ;
WISE, R ;
REDHEAD, RJ .
LANCET, 1990, 335 (8697) :1095-1096